SCLC, EXTENSIVE STAGE
Clinical trials for SCLC, EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SCLC, EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail therapy aims to shrink tough lung cancers
Disease control Not yet recruitingThis study tests a combination of drugs (benmelstobart, anlotinib, and chemo) followed by chest radiation as a first treatment for people with extensive-stage small cell lung cancer that has spread. About 33 adults aged 18-75 will receive the treatment to see if it shrinks tumors…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated May 26, 2026 06:51 UTC
-
Lung cancer drug shows promise in Later-Line treatment
Disease control Not yet recruitingThis study examines the effectiveness and safety of anlotinib, a targeted therapy, for people with advanced non-small cell or small cell lung cancer who have already tried anlotinib and it stopped working. Researchers will review medical records from multiple hospitals to see if …
Matched conditions: SCLC, EXTENSIVE STAGE
Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
New hope for aggressive lung cancer: drug combo plus radiation tested
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer who have not had prior therapy. The treatment combines the drug bemotuzumab with standard chemotherapy and anlotinib, followed by bemotuzumab, anlotinib, and chest radiation. The goal is to se…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New 'Off-the-Shelf' cell therapy takes aim at Hard-to-Treat lung and neuroendocrine cancers
Disease control Not yet recruitingThis early-phase study tests a new cell therapy called NEUK203-13 in people with advanced small cell lung cancer or neuroendocrine tumors that have stopped responding to standard treatments. The therapy uses specially engineered immune cells (CAR-NK cells) made from stem cells, w…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for aggressive lung cancer: Real-World study of toripalimab launches
Disease control Not yet recruitingThis study looks at how well the drug Toripalimab works for people with extensive-stage small cell lung cancer, a fast-growing cancer. Researchers will follow about 1,200 patients in China who are starting Toripalimab as their first treatment. The goal is to see how long the canc…
Matched conditions: SCLC, EXTENSIVE STAGE
Sponsor: Fudan University • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New hope for tough lung cancer: experimental drug IBI363 targets tumors after immunotherapy fails
Disease control Not yet recruitingThis study tests an experimental drug called IBI363 in 35 people with advanced small cell lung cancer that has worsened after at least two prior treatments, including immunotherapy. The goal is to see if IBI363 can shrink tumors or slow the disease. Participants will receive the …
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 18, 2026 11:59 UTC